Literature DB >> 10400426

Immunoglobulin V region gene use and structure suggest antigen selection in AIDS-related primary effusion lymphomas.

F Fais1, G Gaidano, D Capello, A Gloghini, F Ghiotto, S Roncella, A Carbone, N Chiorazzi, M Ferrarini.   

Abstract

Primary effusion lymphoma (PEL) is a lymphoproliferation of B cells infected by Kaposi's sarcoma-associated herpes-virus/human herpesvirus-8 and reflecting a late stage of B cell differentiation close to plasma cell. Apart from viral infection, the pathogenesis of PEL is currently unclear. The aim of the present study was to investigate the role of antigen stimulation and selection in the evolution of PEL. In order to assess the specific variable heavy (VH) and light (VL) genes used by PEL and to define the heavy and light chain isotypes expressed by these lymphomas, immunoglobulin (Ig) genes from seven AIDS-related PEL were sequenced (three cell lines and four primary samples). Most of the samples (five out of seven) used lambda light chain genes; the majority of these (n = 4) belonged to the V lambda 3 family. Two cases expressed mu chains, whereas gamma chains were found in two cases. In all cases, significant deviations from the presumed germline counterpart were found in both the expressed VH and VL genes. Statistical evidence for antigen selection was evident in four out of seven samples studied. Evidence for selection was more frequent in the light chain genes than in the heavy chain genes. Collectively, these data indicate that PEL originate from mature, antigen-experienced B cells and bear implications for the pathogenesis and histogenesis of this lymphoma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10400426     DOI: 10.1038/sj.leu.2401436

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  15 in total

1.  Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155.

Authors:  Rebecca L Skalsky; Mark A Samols; Karlie B Plaisance; Isaac W Boss; Alberto Riva; M Cecilia Lopez; Henry V Baker; Rolf Renne
Journal:  J Virol       Date:  2007-09-19       Impact factor: 5.103

Review 2.  Acquired immunodeficiency syndrome-related malignancies in the era of highly active antiretroviral therapy.

Authors:  Wendy B Bernstein; Richard F Little; Wyndham H Wilson; Robert Yarchoan
Journal:  Int J Hematol       Date:  2006-07       Impact factor: 2.490

3.  X box binding protein XBP-1s transactivates the Kaposi's sarcoma-associated herpesvirus (KSHV) ORF50 promoter, linking plasma cell differentiation to KSHV reactivation from latency.

Authors:  Sam J Wilson; Edward H Tsao; Benjamin L J Webb; Hongtao Ye; Lucy Dalton-Griffin; Christoforos Tsantoulas; Catherine V Gale; Ming-Qing Du; Adrian Whitehouse; Paul Kellam
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

Review 4.  Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases.

Authors:  Dharam V Ablashi; Louise G Chatlynne; James E Whitman; Ethel Cesarman
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

5.  Role of defective Oct-2 and OCA-B expression in immunoglobulin production and Kaposi's sarcoma-associated herpesvirus lytic reactivation in primary effusion lymphoma.

Authors:  Daniel L Di Bartolo; Elizabeth Hyjek; Shannon Keller; Ilaria Guasparri; Hongyu Deng; Ren Sun; Amy Chadburn; Daniel M Knowles; Ethel Cesarman
Journal:  J Virol       Date:  2009-02-18       Impact factor: 5.103

6.  Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile.

Authors:  Richard G Jenner; Karine Maillard; Nicola Cattini; Robin A Weiss; Chris Boshoff; Richard Wooster; Paul Kellam
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-18       Impact factor: 11.205

Review 7.  Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and lymphoproliferative disorders.

Authors:  M-Q Du; C M Bacon; P G Isaacson
Journal:  J Clin Pathol       Date:  2007-12       Impact factor: 3.411

8.  Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins.

Authors:  Stefano A Pileri; Gianluca Gaidano; Pier Luigi Zinzani; Brunangelo Falini; Philippe Gaulard; Emanuele Zucca; Federica Pieri; Eva Berra; Elena Sabattini; Stefano Ascani; Milena Piccioli; Peter W M Johnson; Roberto Giardini; Edoardo Pescarmona; Domenico Novero; Pier Paolo Piccaluga; Teresa Marafioti; Miguel A Alonso; Franco Cavalli
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

9.  Ago HITS-CLIP expands understanding of Kaposi's sarcoma-associated herpesvirus miRNA function in primary effusion lymphomas.

Authors:  Irina Haecker; Lauren A Gay; Yajie Yang; Jianhong Hu; Alison M Morse; Lauren M McIntyre; Rolf Renne
Journal:  PLoS Pathog       Date:  2012-08-23       Impact factor: 6.823

10.  An unusual case of Primary Effusion Lymphoma with aberrant T-cell phenotype in a HIV-negative, HBV-positive, cirrhotic patient, and review of the literature.

Authors:  Charitini Nepka; Dimitrios Kanakis; Maria Samara; Andreas Kapsoritakis; Spyridon Potamianos; Maria Karantana; Georgios Koukoulis
Journal:  Cytojournal       Date:  2012-06-29       Impact factor: 2.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.